LabCorp

2024 saw mixed progress in NSCLC treatment and screening. Sacituzumab govitecan failed to improve OS in EVOKE-01 trial. A BLA for datopotamab deruxtecan was withdrawn. Comprehensive genomic profiling (CGP) was emphasized to address testing gaps. Updated guidelines expanded lung cancer screening eligibility by removing quit time and reducing pack-year criteria.

The Pediatric Clinical Trials Market is projected to grow from US$ 20.1 Billion in 2023 to US$ 33.0 Billion by 2033, with a CAGR of 5.0%. North America led in 2023 with a 39.10% share. Challenges include ethical concerns, limited recruitment, and high costs. Innovations like adaptive trials and digital technologies are enhancing efficiency.

Resonance Health acquired TrialsWest for A$8M, expanding into clinical trial operations. Outsourcing clinical trials enhances efficiency, cost-effectiveness, and regulatory compliance, benefiting companies by optimizing resources and focusing on core activities.

Resonance Health acquired TrialsWest for A$8M, expanding into clinical trials. The global Clinical Trial Outsourcing market was valued at USD 52.39B in 2023 and is projected to reach USD 111.01B by 2032, with a CAGR of 8.7%. Outsourcing offers cost-effectiveness, faster timelines, and regulatory compliance, but faces challenges like rising costs and undisclosed expenses.

Labcorp announces commercial availability of H5 bird flu molecular test in the U.S. to aid in diagnosing human H5N1 infections, developed with CDC support amid a multistate outbreak in poultry and dairy cows.

The Global Decentralized Clinical Trials Market is projected to grow from US$8.3B in 2023 to US$33B by 2033, with a CAGR of 14.8%. North America leads with a 39.7% share, driven by patient-centric approaches, digital health tools, and regulatory support. Oncology dominates applications with a 48.3% share, while interventional trials lead types with 62.4%. AI integration and partnerships are key growth drivers.

The global medical writing market is projected to grow from US$3.44 billion in 2021 to US$9.09 billion by 2031, at a CAGR of 10.2%. This growth is driven by the expansion of pharmaceutical, biotechnology, and medical device industries, increased clinical trials, and stricter regulatory requirements. Key players include Cactus Communications, Certara, Covance, and others.

Tigerlily Foundation and Labcorp developed the I AM INCLUDED framework to enhance inclusivity in clinical trials, involving patients, caregivers, and community leaders. The framework includes 115 best practices across nine themes, aligning with FDA's diversity action plan, and is designed for various clinical trial sites and stakeholders to improve health outcomes for all.